Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mangoceuticals (MGRX) EPS (Basic) (2023 - 2025)

Historic EPS (Basic) for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to -$0.69.

  • Mangoceuticals' EPS (Basic) rose 3947.37% to -$0.69 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.11, marking a year-over-year increase of 4737.73%. This contributed to the annual value of -$4.4 for FY2024, which is 4871.93% up from last year.
  • Latest data reveals that Mangoceuticals reported EPS (Basic) of -$0.69 as of Q3 2025, which was up 3947.37% from -$0.57 recorded in Q2 2025.
  • In the past 5 years, Mangoceuticals' EPS (Basic) ranged from a high of -$0.14 in Q2 2023 and a low of -$1.9 during Q4 2023
  • Over the past 3 years, Mangoceuticals' median EPS (Basic) value was -$1.14 (recorded in 2024), while the average stood at -$1.05.
  • As far as peak fluctuations go, Mangoceuticals' EPS (Basic) plummeted by 87857.14% in 2024, and later surged by 5839.42% in 2025.
  • Over the past 3 years, Mangoceuticals' EPS (Basic) (Quarter) stood at -$1.9 in 2023, then skyrocketed by 48.18% to -$0.98 in 2024, then rose by 29.92% to -$0.69 in 2025.
  • Its EPS (Basic) stands at -$0.69 for Q3 2025, versus -$0.57 for Q2 2025 and -$1.29 for Q1 2025.